RBC Capital Upgrades Incyte (INCY) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 112.96 +0.21 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $112.75 | 52 Week High | $118.49 | |||
| Open | $112.35 | 52 Week Low | $55.00 | |||
| Day High | $113.61 | P/E | N/A | |||
| Day Low | $111.81 | EPS | $-0.56 | |||
| Volume | 323,186 | |||||
